english.prescrire.org > Topics > Advancing healthcare policy > Drug packaging and patient safety > Actions > Methotrexate: room for improvement in packaging and patient information (5/2018)

Advancing healthcare policy

Drug packaging and patient safety

Advancing healthcare policy

Drug packaging and patient safety: Actions
Methotrexate: room for improvement in packaging and patient information (May 2018)

Paris, 29 May 2018

Summary

Prescrire took part in the informal consultation undertaken by the Pharmacovigilance and Risk Assessment Committee (PRAC, the EMA’s medicines safety body), regarding medication errors due to daily instead of weekly administration of methotrexate in non-oncologic indications, and evaluating the effectiveness of risk minimisation measures intended to prevent such errors. Prescrire urges that several root causes which are within the remit of the European Medicines Agency, such as regulation, packaging, labelling and medication safety awareness, not be overlooked.

> Download Prescrire's response to the PRAC consultation (pdf, 144 Ko)

Advancing healthcare policy

Drug packaging and patient safety

Advancing healthcare policy

Drug packaging and patient safety: Actions Methotrexate: room for improvement in packaging and patient information (May 2018)

Drug packaging and patient safety: Actions
Methotrexate: room for improvement in packaging and patient information (May 2018)